Cancer is a leading cause of death worldwide. At imed, we aim to provide innovative solutions to cancer patients through disruptive advances in fundamental scientific discoveries, guided by a deeper understanding of the molecular basis of this disease. This advanced knowledge drives imed drug discovery program towards the identification of druggable targets that fuel cancer progression. imed cancer research program integrates biochemistry, molecular/cell biology and immunology with chemistry, nanotechnology and biotechnology to translate this fundamental knowledge into novel tools for cancer diagnosis, prevention and therapy. Emerging technologies include innovative small molecules as well as advanced delivery systems and devices for newly identified drugs and biologics.